We have over 30 years of experience with the FDA and leading regulatory bodies around the globe. Providing regulatory affairs, QA, CMC in the States, Europe, Brazil, India China and Israel - from R&D and early-stage startups to big pharma, we are highly experienced in a variety of pharmaceutical fields including vaccines, biologicals, cell therapies and ATMPs, botanical drugs, liposomes and medical devices, all in pursuit of treatment for an array of medical conditions.
ADRES EU (Netherlands based) provides international startups access to the EMA interface, providing regulatory, financial and administrative assistance. Our European SME status allows us to conduct various actions on behalf of companies that are not registered in Europe but wish to benefit from EU financial incentives.
From R&D to submission
We were founded with the mission to assist early-stage startups in drug development processes, enabling them to foresee, tackle and cope with the challenges that arise along the way, in order to achieve successful results in line with the highest standards of leading regulatory bodies.
Building Strategies that Translate to Success
Drug-development companies often operate in vague and complex regulatory environments. Our extensive experience differentiates us from others in our ability to predict our clients' possible obstacles ahead of time, tailoring needed services to meet their current and future needs.
We’ve been there, done that
All of ADRES professionals bring hands-on experience from both industry and academia, translating into their ability to predict the best regulatory routes for clients, assess the complexity of their business environment and provide the right solution when in need.
A one-stop-shop
We tailor solutions for clients from A to Z, encompassing every needs they might encounter along the way. From early R&D phases, throughout the development process, production and market launch, we make sure the highest standards of strategy and implement
Company Details
- Employees
- 22
- Founded
- -
- Address
- 2 Yitzhak Modai St., Rehovot,7608804,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Regulatory Affairs, Quality Assurance, Consulting, CMC/Engineering, Biopharma, Biomedicine, FDA, EMA, MOH, Gene Therapy, Combination Products, Novel Drugs, Orphan Drugs, Clinical Studies, Pre-CLinical Studies, IND/IMPD/NDA/BLA, Medical Device.
- HQ
- Rehovot
Adres Int'l Biotech Consultation & Execution Questions
Adres Int'L Biotech Consultation & Execution's LinkedIn profile is https://il.linkedin.com/company/adres-advanced-regulatory-affairs
Adres Int'L Biotech Consultation & Execution has
22 employees.
View email and phone details for 22
employees at Adres Int'L Biotech Consultation & Execution.
Adres Int'L Biotech Consultation & Execution's industry is
Biotechnology Research
Adres Int'L Biotech Consultation & Execution's top competitors are
Impact Biotech,
Restart Biotech Ltd,
Da-Ta Biotech Ltd,
Btg A Ferring Company,
Green Mountain Biotech,
Purple Biotech,
Hanegbi Engineering Ltd,
Denovai Biotech,
Danyel Biotech,
Weizmann Biotech Club.
Adres Int'L Biotech Consultation & Execution's categories are Biotechnology Research
Adres Int'L Biotech Consultation & Execution's founding year is 2009
